Mr Meadows has been a Partner of several healthcare investment funds since 1999. First working with N M Rothschild and then GBS Ventures in Australia, his career moved to Switzerland in 2005 where he completed his MBA.
Upon completing his MBA, Bruce saw the importance in having operational experience as an investor and so joined Stryker Orthopedics, leading their European thoracolumbar spine business. Here he managed a €20 million brand, helping it grow 20% year on year and launching four products during his tenure. Through a matrix organization he had responsibility for the European group’s sales and marketing activities and influenced the manufacturing and R&D activities. Bruce spent a great deal of his time in the operating room, being as close to the healthcare professional and patient as possible, a value he takes with him in his investing career.
Next Bruce was recruited as a founding Partner of Ares Life Sciences, a €1 billion fund investing in all stages of healthcare companies. Here he was involved in several transactions including the Leveraged Buy Out of Esaote, an Italian medical imaging company developing advanced data analysis and connectivity tools. His next investment role was at MD Start, an incubation stage fund where he was involved in founding several companies including CorWave and LimFlow.
Previous to Takeda Digital Ventures, Bruce was the Senior Investment Director of MTIP, a Swiss based healthcare fund. Here Bruce led the group in its digital health strategy that ultimately led to its investment in Tyto Care Inc and Quanta Dialysis Technologies.
Bruce has been a director of many portfolio companies, leading them through IPOs and trade sales.
In his spare time, Bruce has been a part time Professor of Entrepreneurial Finance at Webster University where was able to give back to the next generation of entrepreneurs and help them be better equipped for success. Bruce has an MBA from IMD in Lausanne (Switzerland) and a First Class Honors Degree in Biotechnology from the University of Queensland (Australia).
Upon completing his MBA, Bruce saw the importance in having operational experience as an investor and so joined Stryker Orthopedics, leading their European thoracolumbar spine business. Here he managed a €20 million brand, helping it grow 20% year on year and launching four products during his tenure. Through a matrix organization he had responsibility for the European group’s sales and marketing activities and influenced the manufacturing and R&D activities. Bruce spent a great deal of his time in the operating room, being as close to the healthcare professional and patient as possible, a value he takes with him in his investing career.
Next Bruce was recruited as a founding Partner of Ares Life Sciences, a €1 billion fund investing in all stages of healthcare companies. Here he was involved in several transactions including the Leveraged Buy Out of Esaote, an Italian medical imaging company developing advanced data analysis and connectivity tools. His next investment role was at MD Start, an incubation stage fund where he was involved in founding several companies including CorWave and LimFlow.
Previous to Takeda Digital Ventures, Bruce was the Senior Investment Director of MTIP, a Swiss based healthcare fund. Here Bruce led the group in its digital health strategy that ultimately led to its investment in Tyto Care Inc and Quanta Dialysis Technologies.
Bruce has been a director of many portfolio companies, leading them through IPOs and trade sales.
In his spare time, Bruce has been a part time Professor of Entrepreneurial Finance at Webster University where was able to give back to the next generation of entrepreneurs and help them be better equipped for success. Bruce has an MBA from IMD in Lausanne (Switzerland) and a First Class Honors Degree in Biotechnology from the University of Queensland (Australia).
Speaking In
2:15 PM - 3:15 PM
Monday, June 5
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
